SCHEMBL18223039

SCHEMBL18223039

CC(C)CNCCCNCCC(N)Cc1cccc(-c2cc(CC(N)CCNCCCNCC(C)C)cc(CC(N)CCNCCCNCC(C)C)c2)c1

nearest known ligand 0.34

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ MAP4K4 O95819 1/20 0.34
▸ FNTA P49354 1/20 0.33
▸ FNTB P49356 1/20 0.33
▸ PGGT1B P53609 1/20 0.33
▸ HTR1A P08908 1/20 0.33
▸ GRIA2 P42262 1/20 0.33
▸ PNMT P11086 1/20 0.33
▸ SIGMAR1 Q99720 1/20 0.32
▸ SCN8A Q9UQD0 1/20 0.32
▸ PRKACA P17612 1/20 0.32
▸ PRKACG P22612 1/20 0.32
▸ PRKACB P22694 1/20 0.32
▸ ERAP2 Q6P179 1/20 0.32
▸ ERAP1 Q9NZ08 1/20 0.32
▸ LNPEP Q9UIQ6 1/20 0.32
▸ CHRM2 P08172 2/20 0.32
▸ TAAR1 Q96RJ0 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16247106 0.92 PNMT (0.37) PNMTSIGMAR1CHRM2TAAR1
SCHEMBL16428817 0.91 ERAP2 (0.35) FNTAFNTBPGGT1BERAP2ERAP1
SCHEMBL21632659 0.89 BCHE (0.35) MAP4K4
SCHEMBL21632660 0.86 HDAC1 (0.36) FNTAFNTB
SCHEMBL16429298 0.86 ERAP2 (0.35) FNTAFNTBPGGT1BERAP2ERAP1
SCHEMBL18223040 0.85 CHRNA1 (0.39) GRIA2CHRM2
SCHEMBL16264585 0.82 CHRM2 (0.45) MAP4K4HTR1ASCN8ACHRM2
SCHEMBL16429448 0.81 GRIN1 (0.37) SIGMAR1ERAP2ERAP1LNPEP
SCHEMBL21632587 0.81 HTR2A (0.33) HTR1ASIGMAR1
SCHEMBL16429322 0.81 CHRM2 (0.47) SIGMAR1CHRM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10440955-B2 Methods comprising a biocidal polyamine CURZA GLOBAL, LLC (US) 2019-10-15 — — US disclosed
US-20180125070-A1 COMPOSITIONS AND METHODS COMPRISING A BIOCIDAL POLYAMINE THE UNIVERSITY OF UTAH 2018-05-10 — — US disclosed
US-9839219-B2 Compositions comprising a biocidal polyamine CURZA GLOBAL, LLC (US) 2017-12-12 — — US disclosed
US-20160330962-A1 COMPOSITIONS COMPRISING A BIOCIDAL POLYAMINE CURZA GLOBAL, LLC 2016-11-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160330962-A1 COMPOSITIONS COMPRISING A BIOCIDAL POLYAMINE SRM, SMS, SMOX MAP4K4 4577/4885FNTA 2282/4885FNTB 1445/4885
US-10440955-B2 Methods comprising a biocidal polyamine SRM, SMOX, SMS MAP4K4 4579/4885FNTA 2220/4885FNTB 1638/4885
US-20180125070-A1 COMPOSITIONS AND METHODS COMPRISING A BIOCIDAL POLYAMINE SRM, SMOX, SMS MAP4K4 4552/4885FNTA 2405/4885FNTB 1860/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback